Cargando…

B-cell maturation antigen targeting strategies in multiple myeloma treatment, advantages and disadvantages

B cell maturation antigen (BCMA), a transmembrane glycoprotein member of the tumor necrosis factor receptor superfamily 17 (TNFRSF17), highly expressed on the plasma cells of Multiple myeloma (MM) patients, as well as the normal population. BCMA is used as a biomarker for MM. Two members of the TNF...

Descripción completa

Detalles Bibliográficos
Autores principales:	Nobari, Shirin Teymouri, Nojadeh, Jafar Nouri, Talebi, Mehdi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8832753/ https://www.ncbi.nlm.nih.gov/pubmed/35144648 http://dx.doi.org/10.1186/s12967-022-03285-y

Ejemplares similares

Immunotherapeutic strategies targeting B cell maturation antigen in multiple myeloma
por: Fang, Yi, et al.
Publicado: (2021)

Serum Levels of Interleukin-1β and Disease Progression in Multiple Myeloma Patients: A Case and Control Study
por: Nobari, Shirin Teymouri, et al.
Publicado: (2022)

Advantages and Disadvantages
Publicado: (1917)

Targeting B Cell Maturation Antigen in Patients with Multiple Myeloma: Current Perspectives
por: Shrivastava, Trilok, et al.
Publicado: (2023)

The Advantages and Disadvantages of Specialism
por: Thomas, Reuen
Publicado: (1894)

Chimeric antigen receptor T cell targeting B cell maturation antigen immunotherapy is promising for multiple myeloma
por: Ma, Tiantian, et al.
Publicado: (2019)

B-cell maturation antigen (BCMA) in multiple myeloma: the new frontier of targeted therapies
por: Sanchez, Larysa, et al.
Publicado: (2021)

The Advantages and Disadvantages of Methods Used to Control Liver Bleeding: A Review
por: Nouri, Saeed, et al.
Publicado: (2015)

The Advantages and Disadvantages of Conflict at Work
por: Review, MIT
Publicado: (2018)

Effectiveness studies: advantages and disadvantages
por: Möller, Hans-Jürgen
Publicado: (2011)

Nurses’ Creativity: Advantage or Disadvantage
por: Shahsavari Isfahani, Sara, et al.
Publicado: (2015)

Transoral Thyroidectomy: Advantages and Disadvantages
por: Kim, Wan Wook
Publicado: (2020)

Perineal colostomy: advantages and disadvantages
por: Mulita, Francesk, et al.
Publicado: (2021)

Advantages and Disadvantages of Electronic Cigarettes
por: Sobczak, Andrzej, et al.
Publicado: (2023)

Antibiotic Treatment in End Stage Cancer Patients; Advantages and Disadvantages
por: Mamak, Tahmasebi, et al.
Publicado: (2023)

Advantages and disadvantages of teleworking in healthcare institutions during COVID-19: A systematic review
por: Garavand, Ali, et al.
Publicado: (2022)

B-cell maturation antigen (BCMA) in multiple myeloma: rationale for targeting and current therapeutic approaches
por: Shah, Nina, et al.
Publicado: (2020)

Microsatellite instability in colorectal cancer
por: Nojadeh, Jafar Nouri, et al.
Publicado: (2018)

Neural responses to advantageous and disadvantageous inequity
por: Fliessbach, Klaus, et al.
Publicado: (2012)

Ethyl Chloride—Its Advantages and Disadvantages
Publicado: (1906)

Spinal Anæsthesia, Its Advantages and Disadvantages
por: Struthers, J. W.
Publicado: (1906)

The Advantages and Disadvantages of Human and Animal Lymph
Publicado: (1886)

Integrated Medical Curriculum: Advantages and Disadvantages
por: Quintero, Gustavo A., et al.
Publicado: (2016)

Advantages and Disadvantages of Aluminum as Applied to Dentistry
por: Starr, George O.
Publicado: (1868)

The Advantages and Disadvantages of Esmarch’s Bloodless Method
Publicado: (1875)

Targeting B Cell Maturation Antigen (BCMA) in Multiple Myeloma: Potential Uses of BCMA-Based Immunotherapy
por: Cho, Shih-Feng, et al.
Publicado: (2018)

Targeting B-cell maturation antigen increases sensitivity of multiple myeloma cells to MCL-1 inhibition
por: Cuenca, Marta, et al.
Publicado: (2021)

Risk of infections with B-cell maturation antigen-directed immunotherapy in multiple myeloma
por: Mohan, Meera, et al.
Publicado: (2022)

Role of Anti-B-Cell Maturation Antigen (BCMA) in the Management of Multiple Myeloma
por: Rinaldi, Ikhwan, et al.
Publicado: (2022)

Soluble B-cell maturation antigen as a monitoring marker for multiple myeloma
por: Wiedemann, Ádám, et al.
Publicado: (2023)

A compound chimeric antigen receptor strategy for targeting multiple myeloma
por: Chen, K H, et al.
Publicado: (2018)

Potential advantages and disadvantages of an endgame strategy: a ‘sinking lid’ on tobacco supply
por: Wilson, Nick, et al.
Publicado: (2013)

Work From Home in Academic Radiology Departments: Advantages, Disadvantages and Strategies for the Future
por: Recht, Michael P.
Publicado: (2023)

CRISPR/Cas9 genome editing for neurodegenerative diseases
por: Nouri Nojadeh, Jafar, et al.
Publicado: (2023)

Pre-clinical validation of B cell maturation antigen (BCMA) as a target for T cell immunotherapy of multiple myeloma
por: Bu, De-Xiu, et al.
Publicado: (2018)

B-Cell Maturation Antigen (BCMA) as a Target for New Drug Development in Relapsed and/or Refractory Multiple Myeloma
por: Abramson, Hanley N.
Publicado: (2020)

Chimeric Antigen Receptor-Modified T Cell Therapy in Multiple Myeloma: Beyond B Cell Maturation Antigen
por: Timmers, Marijke, et al.
Publicado: (2019)

Advantages and Disadvantages of Supersymmetry Breaking at Low Energies
por: Pomarol, Alex
Publicado: (1996)

Overlapping and distinct representations of advantageous and disadvantageous inequality
por: Yu, Rongjun, et al.
Publicado: (2013)

Nanomaterials in the application of tumor vaccines: advantages and disadvantages
por: Li, XD, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_hj1jc5lm6n07t4snm7qn5ql2m8